(CIRB) Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma

ECOG-EAF151
NCT03115333
Cancer - Brain and Nervous System
Daniel Chow
Open
Diagnostic
Avastin, Bevacizumab, Gadobutrol
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.